Benoît B. S.
- Country
- France
- Department
- Dermatology
Research Overview
- Phase I/II Study on the Tolerance and Efficacy of Daratumumab in Patients with Active Toxic Epidermal Necrolysis
- Randomized Controlled Trial Evaluating Systemic Corticosteroids Versus Placebo in Acute Severe Erythema Multiforme: Prednisone and Methylprednisolone Acetate Analysis
- Assessment of Filgrastim Efficacy in Patients with Severe Bullous Drug Eruptions: Lyell Syndrome and Stevens-Johnson Syndrome
Data & Insights
Has run more than one trial at 1 of 15 partner sites.
Specializations
Severe Dermatological Conditions
This investigator specializes in treating severe cutaneous adverse reactions, with particular focus on Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS). Their research encompasses innovative therapeutic approaches for these life-threatening conditions.
- Severe Erythema Multiforme
- Lyell Syndrome
- Bullous Drug Eruptions
The investigator explores novel treatment modalities including immunological interventions and systemic therapies for severe skin reactions.
Immunological Therapeutics
Their research extends into immunomodulatory treatments for severe dermatological conditions, investigating targeted therapies such as anti-CD38 antibodies and growth factors in disease management.
- Biological Response Modifiers
- Systemic Corticosteroid Therapy
- Targeted Immunological Interventions
The investigator focuses on developing therapeutic strategies for acute phase treatment of severe cutaneous conditions.
Emergency Dermatology
The investigator specializes in acute management of severe dermatological emergencies, particularly focusing on hospital-based treatment protocols for life-threatening skin conditions.
- Disease Progression Control
- Symptomatic Treatment Optimization
- Emergency Intervention Protocols
Their work encompasses acute care strategies and therapeutic interventions for critical dermatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.